Editorial Board

Dr. Zhanhe Wu, MD, PhD, FFSc (RCPA)

Dr. Zhanhe Wu, MD, PhD, FFSc (RCPA)
Senior Medical Scientist
Western Sydney Genome Diagnostics, The Children’s Hospital at Westmead
University of Sydney

Biography :

Dr Zhanhe Wu graduated from Harbin Medical University, China and worked in cardiology/haematology clinic for 8 years. He received his Master degree on the project of hematopoietic stem cells of leukaemia in 1985 and received his PhD in 1993 from University of New South Wales on the topic of Haematology/Immunology, identified IgG Fc receptors on 5 different types of hematopoietic cells/lines (megakaryocytic lineage) which it is important for the studies in cardiovascular disease, thrombotic disease, cancer and immune related diseases. He worked for 2 years on the topic of fetal and maternal immune interactions at University of Sydney from 1995 to 1996 as a Senior Scientist, research project in charge and postgraduate student supervisor. Since 1996, he has been working in the field of human genetic disease studies, mainly in the genetic cause of early fetal loss, tissue/cell culture, chromosomal instability syndromes and inherited bone marrow failure syndromes including Fanconi anemia (it is named as the prone cancer syndrome and paradigm for cancer and aging research), hematologic malignancies mainly in leukemia and lymphoma in the Sydney Genome Diagnostics, Western Sydney Genetics Program, The Children’s Westmead, affiliated to University or Sydney. He is the Fanconi anemia testing guider for the international Fanconi anemia research fund (the only one in Australia) and invited more than 20 times as the keynote scientific conference speaker for several countries including China, New Zealand and Vietnam.

Research Interest :

Dr Zhan he Wu has broad interest in medical research mainly in Cell Biology, Tissue Culture/Cell Banking, studies on genetic cause of Fetal loss and Fetal Genetic Pathology, Laboratory Diagnosis of Human Genetic Diseases, particularly in chromosomal instability (including Fanconi Anemia) and Inherited Bone Marrow Failure Syndromes and other genetic rare diseases, germ line mutation associated Cancer and Leukemia, haematopoiesis and malignant hematology, Humoral Immune and Immuno phenotyping, Quality Control for Medical Laboratory Editorial in Medical Journal.